Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS) (NCT01606631) | Clinical Trial Compass
CompletedNot Applicable
Role of Beta-blockers in the Prevention on the Arisen of a Severe Sepsis (TESS)
France2,444 participantsStarted 2009-09
Plain-language summary
The severe sepsis (SS) and toxic shock (TS) are both frequent and severe complications of infectious diseases. They are one of the top ten causes of death in industrialized countries. But an eventual protective role of beta-blockers (anti-hypertensive drug) in their occurrence on a community infection has never been studied. The objective of this study is to evaluate this role.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Common characteristics of cases and controls:
* Patients aged of more than 18 years old
* Hospitalized patients, during the period of study, via the ICU of the participating hospital center, for a community infectious pathology:
* lower respiratory infections (pneumonia)
* intra-abdominal infections (cholangitis, diverticulitis, peritonitis)
* urinary parenchymal infection (pyelonephritis complicated or without abscess, prostatitis, orchitis, epididymitis)
* infections of skin and soft tissue infections (cellulitis, fasciitis)
* meningitis, endocarditis, osteo-articular infections, salpingitis
Definition of cases:
* Patient included in the study and admitted to the emergency service either directly from ICU or after a hospitalization in a specialty for severe sepsis or septic shock on their infectious disease community.
Definition of controls:
* Patient included in the study with an infectious disease community, admitted to a specialty, and have not progressed to severe sepsis or septic shock before being released from the hospital.
Non inclusion Criteria:
* Opposition of the patient to the IT processing of its data within the framework of this observational study.
* Exclusion criteria: Occurrence, during hospitalization, a severe sepsis or septic shock associated with a nosocomial superinfection.
What they're measuring
1
The primary outcome is the occurrence of severe sepsis, moving toward or away from septic shock.
Timeframe: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks